RxDoctor Payments Data

Megan Herring, DPM

Podiatrist · Little Rock, ARNPI 1023538568

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $348 and has fallen 62.9% since, to $129 in 2025. That places this record below the midpoint for podiatrist clinicians in AR, where the typical reported total is $1,089.

$1,292in general payments, 2019–2025

Across 43 payments — averaging $30.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$265
  • Nevro Corp.$171
  • Organogenesis Inc.$151
  • Paragon 28, Inc.$146
  • Johnson & Johnson$136
  • Zimmer Biomet$86
  • plus $337 from 13 others

What the payments were for

  • Food & beverage$1,292100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,292 in reported general payments places this provider in the 50th percentile of 35 podiatrist providers in Arkansas.

See all podiatrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$201,965
Medicare patients
301
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole40$997
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$380
Doxycycline Hyclate32$233
Gabapentin14$217
Terbinafine Hcl23$186
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$176
Meloxicam29$125
Mupirocin11$74
Ondansetron Hcl12$44

Paid to pharmacies, not to this prescriber.

Other podiatrist in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →